Physician profile
Robert L Rebert
NPI 1346451663
$1,571.43
in general payments reported to CMS, 2019-2025
8 companies · $250 in 2025
The $250 reported for 2025 was more than what 80% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2021: $269 · 2023: $485 · 2024: $333 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $475 · Entertainment: $396 · Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $475.00 |
| Entertainment | $395.84 |
| Food and Beverage | $196.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $475.00 | 2024-2025 | |
| Keystone Dental INC. | $395.84 | 2023 | |
| Zimmer Biomet Holdings, INC. | $388.07 | 2019-2021 | |
| Dentsply Sirona INC | $120.98 | 2023-2024 | Implant Dentistry, Suresmile |
| Coltene Whaledent INC. | $100.00 | 2019 | |
| Kerr Corporation | $37.79 | 2023 | Fill/Obturation |
| Nobel Biocare USA | $37.78 | 2023 | Nobelactive |
| Philips North America LLC | $15.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.